Coeptis Pharmaceuticals
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
105 Bradford Rd Ste 420, Wexford, Pennsy...Phone Number
(724) 934-6467Website
coeptis.investorroom.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Coeptis Pharmaceuticals
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company that focuses on developing innovative cell therapy platforms aimed at treating cancer, autoimmune, and infectious diseases. Their therapeutic portfolio includes licensed assets such as an allogeneic cellular immunotherapy platform and clinical-stage natural killer cell therapy technology. Additionally, Coeptis is advancing a universal, multi-antigen CAR technology and developing cell therapy diagnostic platforms in collaboration with leading researchers. The company has also expanded into technology with the acquisition of AI-powered marketing software, positioning itself at the forefront of biopharma innovation.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Coeptis Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Coeptis Pharmaceuticals had a recent Job posting/layoffs
Check if Coeptis Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Coeptis Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Coeptis Pharmaceuticals
Check out if Coeptis Pharmaceuticals is spiking on competitors!
Coeptis Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Coeptis Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Coeptis Pharmaceuticals has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Coeptis Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Coeptis Pharmaceuticals
Compare insights from companies similar to Coeptis Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Coeptis Pharmaceuticals
<$5M
11-50
Private
-
2017
N/A
Company Profile Activity
Activity Insights
Coeptis Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Coeptis Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Coeptis Pharmaceuticals.
Coeptis Pharmaceuticals Tech Stack
A closer look at the technologies used by Coeptis Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Coeptis Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company that focuses on developing innovative cell therapy platforms aimed at treating cancer, autoimmune, and infectious diseases. Their therapeutic portfolio includes licensed assets such as an allogeneic cellular immunotherapy platform and clinical-stage natural killer cel... Read More
